Loading…

Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival

We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in c...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cellular biochemistry 2003-05, Vol.89 (1), p.165-179
Main Authors: Gingery, Anne, Bradley, Elizabeth, Shaw, Aubie, Oursler, Merry Jo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3
cites cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3
container_end_page 179
container_issue 1
container_start_page 165
container_title Journal of cellular biochemistry
container_volume 89
creator Gingery, Anne
Bradley, Elizabeth
Shaw, Aubie
Oursler, Merry Jo
description We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.10503
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19721935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19721935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</originalsourceid><addsrcrecordid>eNp1kD1OAzEQhS0EEuGn4AaukCiWjO39iUuIkgALAaEgSsvxOorBWYe1Q9ircQjOhCFARzGaN5rvveIhdETglADQ7pOaRpEB20IdArxI0jxNt1EHCgYJZYTuoj3vnwCAc0Y7aH03d345l8FUrTW18yY4i1nybGrpNVbONVWUQdsWSxXMa5Qeh7nGN4OyO7gvsawrfFZOuuPhx_s5XsowX8s2Ig4vpKlDHOx80E5Z6QP2q-Y1htgDtDOT1uvDn72PHoaDSf8iub4dXfbPrhPFWM6SSgHToAvoSU1nxZSmBQdOs3xKOcQnySogXKXTLB7A8hxSlvVmrCdTqaiq2D463uQuG_ey0j6IhfFKWytr7VZeEF5QwlkWwZMNqBrnfaNnYtmYhWxaQUB8VStiteK72sh2N-zaWN3-D4qr_vmvI9k4TKzi7c8hm2eRF6zIxON4JHh-X_YgLwWwT2lpisA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19721935</pqid></control><display><type>article</type><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><source>Wiley</source><creator>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</creator><creatorcontrib>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</creatorcontrib><description>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.10503</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AKT ; apoptosis ; ERK ; MEK ; NFκB ; osteoclast ; PI3K</subject><ispartof>Journal of cellular biochemistry, 2003-05, Vol.89 (1), p.165-179</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</citedby><cites>FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gingery, Anne</creatorcontrib><creatorcontrib>Bradley, Elizabeth</creatorcontrib><creatorcontrib>Shaw, Aubie</creatorcontrib><creatorcontrib>Oursler, Merry Jo</creatorcontrib><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</description><subject>AKT</subject><subject>apoptosis</subject><subject>ERK</subject><subject>MEK</subject><subject>NFκB</subject><subject>osteoclast</subject><subject>PI3K</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp1kD1OAzEQhS0EEuGn4AaukCiWjO39iUuIkgALAaEgSsvxOorBWYe1Q9ircQjOhCFARzGaN5rvveIhdETglADQ7pOaRpEB20IdArxI0jxNt1EHCgYJZYTuoj3vnwCAc0Y7aH03d345l8FUrTW18yY4i1nybGrpNVbONVWUQdsWSxXMa5Qeh7nGN4OyO7gvsawrfFZOuuPhx_s5XsowX8s2Ig4vpKlDHOx80E5Z6QP2q-Y1htgDtDOT1uvDn72PHoaDSf8iub4dXfbPrhPFWM6SSgHToAvoSU1nxZSmBQdOs3xKOcQnySogXKXTLB7A8hxSlvVmrCdTqaiq2D463uQuG_ey0j6IhfFKWytr7VZeEF5QwlkWwZMNqBrnfaNnYtmYhWxaQUB8VStiteK72sh2N-zaWN3-D4qr_vmvI9k4TKzi7c8hm2eRF6zIxON4JHh-X_YgLwWwT2lpisA</recordid><startdate>20030501</startdate><enddate>20030501</enddate><creator>Gingery, Anne</creator><creator>Bradley, Elizabeth</creator><creator>Shaw, Aubie</creator><creator>Oursler, Merry Jo</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope></search><sort><creationdate>20030501</creationdate><title>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</title><author>Gingery, Anne ; Bradley, Elizabeth ; Shaw, Aubie ; Oursler, Merry Jo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>AKT</topic><topic>apoptosis</topic><topic>ERK</topic><topic>MEK</topic><topic>NFκB</topic><topic>osteoclast</topic><topic>PI3K</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gingery, Anne</creatorcontrib><creatorcontrib>Bradley, Elizabeth</creatorcontrib><creatorcontrib>Shaw, Aubie</creatorcontrib><creatorcontrib>Oursler, Merry Jo</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gingery, Anne</au><au>Bradley, Elizabeth</au><au>Shaw, Aubie</au><au>Oursler, Merry Jo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2003-05-01</date><risdate>2003</risdate><volume>89</volume><issue>1</issue><spage>165</spage><epage>179</epage><pages>165-179</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>We have examined highly purified osteoclasts that were generated in vitro from murine co‐culture of marrow precursors with stromal support cells and have found evidence of activation of the MEK/ERK and AKT/NFκB survival pathways. Many mature marrow‐derived osteoclasts survived for at least 48 h in culture whether or not they are maintained with stromal cells. Moreover, supplementing purified osteoclasts with RANKL and/or M‐CSF had no impact on their survival pattern. In addition, spleen‐derived osteoclasts generated with RANKL and M‐CSF treatment exhibited a similar survival pattern. Blocking MEK, AKT, or NFκB activity resulted in apoptosis of many, but not all, of the osteoclasts in purified marrow‐derived osteoclasts, marrow‐derived osteoclasts co‐cultured with stromal cells, and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. These data support that both the MEK/ERK and AKT/NFκB pathways contribute to osteoclast survival. Since PI3K has been shown to activate either of these pathways, we have examined its role in osteoclast survival. PI3K inhibition caused apoptosis of nearly all osteoclasts in purified and co‐cultured marrow‐derived osteoclasts and spleen‐derived osteoclasts maintained with RANKL and M‐CSF. Interestingly, in marrow‐derived co‐cultures, the apoptotic response was restricted to osteoclasts as there was no evidence of stromal support cell apoptosis. PI3K inhibition also blocked MEK1/2, ERK1/2, and AKT phosphorylation and NFκB activation in purified osteoclasts. Simultaneous blockage of both AKT and MEK1/2 caused rapid apoptosis of nearly all osteoclasts, mimicking the response to PI3K inhibition. These data reveal that PI3K coordinately activates two distinct survival pathways that are both important in osteoclast survival. J. Cell. Biochem. 89: 165–179, 2003. © 2003 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/jcb.10503</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2003-05, Vol.89 (1), p.165-179
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_19721935
source Wiley
subjects AKT
apoptosis
ERK
MEK
NFκB
osteoclast
PI3K
title Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphatidylinositol%203-kinase%20coordinately%20activates%20the%20MEK/ERK%20and%20AKT/NF%CE%BAB%20pathways%20to%20maintain%20osteoclast%20survival&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Gingery,%20Anne&rft.date=2003-05-01&rft.volume=89&rft.issue=1&rft.spage=165&rft.epage=179&rft.pages=165-179&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.10503&rft_dat=%3Cproquest_cross%3E19721935%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3363-dc03e0e708ae2f7b247909256b290dc015d019c4b5dc0036604358f38a4ac2cd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19721935&rft_id=info:pmid/&rfr_iscdi=true